US1266501006
US1266501006
CVS Health Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 110.2B EUR | 132.21B EUR | 91.43B EUR | 100.87B EUR |
Enterprise Value | 174.84B EUR | 197.19B EUR | 160.23B EUR | 172.36B EUR |
Valuation Multiples | ||||
Trailing P/E | 23.1x | 27.04x | 31.18x | -- |
Forward P/E | 10.1x | -- | -- | -- |
Price to Sales | 0.27x | 0.32x | 0.22x | 0.33x |
Price to Book | 1.38x | 1.66x | 1.18x | 1.34x |
EV/Revenue | 0.42x | 0.48x | 0.39x | 0.56x |
EV/EBITDA | 10.48x | 10.57x | 9.79x | 16.34x |
Price to FCF (P/FCF) | 13.64x | 11.24x | 12.37x | 25.25x |
EV/FCF | 21.65x | 16.77x | 21.67x | 43.16x |
FCF Yield | 7.33% | 8.89% | 8.09% | 3.96% |